Anti-REPS2/ POB1 monoclonal antibody

Anti-REPS2/ POB1 antibody for FACS & in-vivo assay

Target products collectionGo to REPS2/REPS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2599-Ab-1/ GM-Tg-hg-MP2599-Ab-2Anti-Human REPS2 monoclonal antibodyHuman
GM-Tg-rg-MP2599-Ab-1/ GM-Tg-rg-MP2599-Ab-2Anti-Rat REPS2 monoclonal antibodyRat
GM-Tg-mg-MP2599-Ab-1/ GM-Tg-mg-MP2599-Ab-2Anti-Mouse REPS2 monoclonal antibodyMouse
GM-Tg-cynog-MP2599-Ab-1/ GM-Tg-cynog-MP2599-Ab-2Anti-Cynomolgus/ Rhesus macaque REPS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2599-Ab-1/ GM-Tg-felg-MP2599-Ab-2Anti-Feline REPS2 monoclonal antibodyFeline
GM-Tg-cang-MP2599-Ab-1/ GM-Tg-cang-MP2599-Ab-2Anti-Canine REPS2 monoclonal antibodyCanine
GM-Tg-bovg-MP2599-Ab-1/ GM-Tg-bovg-MP2599-Ab-2Anti-Bovine REPS2 monoclonal antibodyBovine
GM-Tg-equg-MP2599-Ab-1/ GM-Tg-equg-MP2599-Ab-2Anti-Equine REPS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2599-Ab-1/ GM-Tg-hg-MP2599-Ab-2; GM-Tg-rg-MP2599-Ab-1/ GM-Tg-rg-MP2599-Ab-2;
GM-Tg-mg-MP2599-Ab-1/ GM-Tg-mg-MP2599-Ab-2; GM-Tg-cynog-MP2599-Ab-1/ GM-Tg-cynog-MP2599-Ab-2;
GM-Tg-felg-MP2599-Ab-1/ GM-Tg-felg-MP2599-Ab-2; GM-Tg-cang-MP2599-Ab-1/ GM-Tg-cang-MP2599-Ab-2;
GM-Tg-bovg-MP2599-Ab-1/ GM-Tg-bovg-MP2599-Ab-2; GM-Tg-equg-MP2599-Ab-1/ GM-Tg-equg-MP2599-Ab-2
Products NameAnti-REPS2 monoclonal antibody
Formatmab
Target NameREPS2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-REPS2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species REPS2/ POB1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000771human REPS2 Lentivirus particle
    ORF Viral VectorpGMLV000771human REPS2 Lentivirus plasmid


    Target information

    Target IDGM-MP2599
    Target NameREPS2
    Gene ID9185,194590,363466,721024,491756,101087303,526887,100056954
    Gene Symbol and SynonymsPOB1,REPS2,Reps2-ps1,RGD1561642
    Uniprot AccessionQ8NFH8
    Uniprot Entry NameREPS2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000169891
    Target ClassificationN/A

    The target: REPS2, gene name: REPS2, also named as POB1. The product of this gene is part of a protein complex that regulates the endocytosis of growth factor receptors. The encoded protein directly interacts with a GTPase activating protein that functions downstream of the small G protein Ral. Its expression can negatively affect receptor internalization and inhibit growth factor signaling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.